0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

INTRAVENOUS USE OF PROCAINE IN GENERAL ANESTHESIA

G. W. EDMONDS, M.D.; W. H. COMER, M.D.; J. D. KENNEDY, M.D.; I. B. TAYLOR, M.D.
JAMA. 1949;141(11):761-767. doi:10.1001/jama.1949.02910110013005.
Text Size: A A A
Published online

Procaine, or the hydrochloride of beta-diethylaminoethanol para-aminobenzoate, was synthesized by Einhorn1 in 1904 (published in 1905). Its widespread use and popularity produced many experimental and clinical reports on the pharmacology and toxicology of procaine and related compounds. These were mainly related to the subcutaneous use of the compound.

EVALUATION OF PROCAINE IN THE LITERATURE  Eggleston and Hatcher2 in 1916 and 1919, working with cats, reported that toxic effects of procaine were in direct proportion to the rate of introduction of the drug into the blood stream. They found that the injection of a sublethal dose produced an abrupt fall in blood pressure (believed to be due to cardiac effect) and cessation of respiration, followed by brief but severe clonic convulsions. This sublethal dose could be repeated with procaine in twenty minute periods without evidence of accumulation. Also, continuous intravenous administration of the compound

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();